文献库搜索 | GeneLibs

Liu(KK),Wang(MK),Hou(TT),Gong(WJ),Wu(SL) Discov Oncol 2026-03-11

...KRAS mutation,” and “deep learning” as the most current research frontiers. CONCLUSIONS: This analysis underscores the p...

Stickler(S),Eggerstorfer(MT),Rieche(M),Ars... Sci Rep 2026-03-11

...KRAS mutations or amplifications. MDA-MB-231 cells, which have a KRAS G13D mutation and express HER2-103, were previousl...

Tiede(KOM),Teixeira(MF),Moura(M),Chiaini(O... Sci Rep 2026-03-11

...KRAS-targeted agents. These findings validate direct KRAS inhibition as a breakthrough concept in PDAC but are tempered ...

Marin(AM),Timoner(BE),Araújo(DD),Uno(M),Al... Sci Rep 2026-03-11

...KRAS, TP53, CDKN2A, and SMAD4 in the cfDNA of 55 PDAC patients, using a total of 133 blood samples. After that, we ident...

Patel(AAH),Dzanan(JJ),Ali(KX),Eklund(EA),A... Nature 2026-04-00

...KRAS-driven lung adenocarcinoma, limiting primary tumour growth while promoting metastatic dissemination through epigene...

Xu(X),Gu(H),Cha(Z),Zhang(B),Yuan(S),Ding(X... Mol Ther 2026-07-01

Adoptive T cell transfer targeting KRAS G12D can induce tumor regression in advanced epithelial cancers. The safety, eff...

Li(SS),Wu(HX),Li(YB),Zhao(LM),Su(XH),Xiong... Zhongguo Zhong Yao Za Zhi 2026-02-00

...KRAS), RAF proto-oncogene serine/threonine-protein kinase 1(RAF1), and extracellular signal-regulated kinase(ERK), were ...

de Oliveira Cavagna(R),Escremim de Paula(F... Lancet Reg Health Am 2026-04-00

...KRAS (Kirsten Rat Sarcoma Viral) [289 (25.6%)], and EGFR (Epidermal Growth Factor Receptor) [228 (20.6%)] genes. TP53 mu...

Hao(S),Zhao(S),Shi(L),Zhong(L),Wei(H),Jiao... J Thorac Dis 2026-02-28

...KRAS G12C, and HER2 mutations. While these alterations collectively account for approximately 20% of NSCLC, evidence gui...

Zhang(F),Jiang(Z),Gao(Y),Wang(D),Yue(S) J Gastrointest Oncol 2026-02-28

...KRAS and TP53. This study established a significant link between mitochondrial dysfunction and PDAC molecular subtypes, ...